151 related articles for article (PubMed ID: 23680607)
1. Pseudohypoaldosteronism type 1: management issues.
Sharma R; Pandey M; Kanwal SK; Zennaro MC
Indian Pediatr; 2013 Mar; 50(3):331-3. PubMed ID: 23680607
[TBL] [Abstract][Full Text] [Related]
2. Case report: Early molecular confirmation and sodium polystyrene sulfonate management of systemic pseudohypoaldosteronism type I.
Alkhatib EH; Bartlett D; Kanakatti Shankar R; Regier D; Merchant N
Front Endocrinol (Lausanne); 2023; 14():1297335. PubMed ID: 38288475
[TBL] [Abstract][Full Text] [Related]
3. Life threatening hyperkalemia in a neonate with pseudo-hypoaldosteronism.
Choudhry S; Najam Y
J Pak Med Assoc; 2012 Mar; 62(3):287-8. PubMed ID: 22764468
[TBL] [Abstract][Full Text] [Related]
4. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.
Serra G; Antona V; D'Alessandro MM; Maggio MC; Verde V; Corsello G
Ital J Pediatr; 2021 Jun; 47(1):138. PubMed ID: 34134742
[TBL] [Abstract][Full Text] [Related]
5. A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.
Dirlewanger M; Huser D; Zennaro MC; Girardin E; Schild L; Schwitzgebel VM
Am J Physiol Endocrinol Metab; 2011 Sep; 301(3):E467-73. PubMed ID: 21653223
[TBL] [Abstract][Full Text] [Related]
6. [Multiple type I pseudohypoaldosteronism: neonatal management and outcome].
Cristina De Frutos Martínez M; Elorza Martínez M; Salas Hernández S; García Sánchez P; Jaso Cortés E; Pérez-Rodríguez J; Quero Jiménez J
An Esp Pediatr; 2000 Jan; 52(1):47-51. PubMed ID: 11003859
[TBL] [Abstract][Full Text] [Related]
7. Pseudohypoaldosteronisms, report on a 10-patient series.
Belot A; Ranchin B; Fichtner C; Pujo L; Rossier BC; Liutkus A; Morlat C; Nicolino M; Zennaro MC; Cochat P
Nephrol Dial Transplant; 2008 May; 23(5):1636-41. PubMed ID: 18424465
[TBL] [Abstract][Full Text] [Related]
8. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
Schweiger B; Moriarty MW; Cadnapaphornchai MA
Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
[TBL] [Abstract][Full Text] [Related]
9. A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.
Lee SE; Jung YH; Han KH; Lee HK; Kang HG; Ha IS; Choi Y; Cheong HI
Korean J Pediatr; 2011 Feb; 54(2):90-3. PubMed ID: 21503203
[TBL] [Abstract][Full Text] [Related]
10. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
Fernandes-Rosa FL; Antonini SR
Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
[TBL] [Abstract][Full Text] [Related]
11. Critical points in the management of pseudohypoaldosteronism type 1.
Güran T; Değirmenci S; Bulut İK; Say A; Riepe FG; Güran Ö
J Clin Res Pediatr Endocrinol; 2011; 3(2):98-100. PubMed ID: 21750640
[TBL] [Abstract][Full Text] [Related]
12. Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1Aand SCNN1BGenes.
Cayir A; Demirelli Y; Yildiz D; Kahveci H; Yarali O; Kurnaz E; Vuralli D; Demirbilek H
Horm Res Paediatr; 2019; 91(3):175-185. PubMed ID: 31018202
[TBL] [Abstract][Full Text] [Related]
13. A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism Type 1.
Dogan CS; Erdem D; Mesut P; Merve A; Sema A; Iffet B; Afig B
J Pediatr Endocrinol Metab; 2012; 25(9-10):1035-9. PubMed ID: 23426840
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
Bonny O; Knoers N; Monnens L; Rossier BC
Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
[TBL] [Abstract][Full Text] [Related]
15. Pseudohypoaldosteronism type 1 due to novel variants of SCNN1B gene.
Nobel YR; Lodish MB; Raygada M; Rivero JD; Faucz FR; Abraham SB; Lyssikatos C; Belyavskaya E; Stratakis CA; Zilbermint M
Endocrinol Diabetes Metab Case Rep; 2016; 2016():150104. PubMed ID: 26807262
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
[TBL] [Abstract][Full Text] [Related]
17. Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1.
Welzel M; Akin L; Büscher A; Güran T; Hauffa BP; Högler W; Leonards J; Karges B; Kentrup H; Kirel B; Senses EE; Tekin N; Holterhus PM; Riepe FG
Eur J Endocrinol; 2013 May; 168(5):707-15. PubMed ID: 23416952
[TBL] [Abstract][Full Text] [Related]
18. Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism.
Adachi M; Asakura Y; Muroya K; Tajima T; Fujieda K; Kuribayashi E; Uchida S
Clin Exp Nephrol; 2010 Jun; 14(3):228-32. PubMed ID: 20376516
[TBL] [Abstract][Full Text] [Related]
19. A mild and transient form of autosomal recessive pseudohypoaldosteronism type 1 caused by a novel mutation in the
Efthymiadou A; Gautschi I; van Bemmelen MX; Sertedaki A; Giannakopoulos A; Chrousos G; Schild L; Chrysis D
Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E1-E9. PubMed ID: 37134141
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte Na+,K+-ATPase and nasal potential in pseudohypoaldosteronism.
Bistritzer T; Kerem E; Berkovitch M; Rapoport MJ; Evans S; Aladjem M
Clin Endocrinol (Oxf); 2002 May; 56(5):575-80. PubMed ID: 12030906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
